| Registered number: 12463589 | ||||||||
| FOR THE YEAR ENDED 28 FEBRUARY 2025 | ||||||||
| Prepared By: | ||||||||
| Reed-Ransted | ||||||||
| Chartered Accountants | ||||||||
| 2 Burhill Grove | ||||||||
| Pinner | ||||||||
| Middlesex | ||||||||
| HA5 3DW | ||||||||
| MEDICAL ACCESS SPECIALISTS LIMITED | ||||||||
| ACCOUNTS | ||||||||
| FOR THE YEAR ENDED 28 FEBRUARY 2025 | ||||||||
| DIRECTORS | ||||||||
| REGISTERED OFFICE | ||||||||
| Middlesex | ||||||||
| COMPANY DETAILS | ||||||||
| Private company limited by shares registered in EW - England and Wales, registered number 12463589 | ||||||||
| PLACE OF BUSINESS | ||||||||
| Windwhistle Cottage, Hawkchurch, Axminster, EX13 5XD. | ||||||||
| ACCOUNTANTS | ||||||||
| Reed-Ransted | ||||||||
| Chartered Accountants | ||||||||
| 2 Burhill Grove | ||||||||
| Pinner | ||||||||
| Middlesex | ||||||||
| HA5 3DW | ||||||||
| MEDICAL ACCESS SPECIALISTS LIMITED | ||||||||
| ACCOUNTS | ||||||||
| FOR THEYEARENDED28 FEBRUARY 2025 | ||||||||
| CONTENTS | ||||||||
| Page | ||||||||
| Directors' Report | - | |||||||
| Accountants' Report | - | |||||||
| Statement Of Comprehensive Income | - | |||||||
| Balance Sheet | 3 | |||||||
| Notes To The Accounts | 4 | |||||||
| The following do not form part of the statutory financial statements: | ||||||||
| Trading And Profit And Loss Account | - | |||||||
| Profit And Loss Account Summaries | - | |||||||
| MEDICAL ACCESS SPECIALISTS LIMITED | ||||||||
| BALANCE SHEET AT | ||||||||||
| Registered number: 12463589 | ||||||||||
| 2025 | 2024 | |||||||||
| Notes | £ | £ | ||||||||
| CURRENT ASSETS | ||||||||||
| Stock | ||||||||||
| Debtors | 4 | |||||||||
| Cash at bank and in hand | ||||||||||
| 1,601 | 2,864 | |||||||||
| CREDITORS: Amounts falling due within one year | 5 | |||||||||
| NET CURRENT LIABILITIES | ( | (12,543) | ||||||||
| TOTAL ASSETS LESS CURRENT LIABILITIES | ( | ( | ||||||||
| CAPITAL AND RESERVES | ||||||||||
| Called up share capital | 6 | |||||||||
| Profit and loss account | (3,332) | (12,743) | ||||||||
| SHAREHOLDERS' FUNDS | ( | ( | ||||||||
| Approved by the board on | ||||||||||
| ............................. | ||||||||||
| Director | ||||||||||
| MEDICAL ACCESS SPECIALISTS LIMITED | ||||||||
| NOTES TO THE ACCOUNTS | ||||||||||
| FOR THE YEAR ENDED 28 FEBRUARY 2025 | ||||||||||
| 1. ACCOUNTING POLICIES |
| 1a. Basis Of Accounting | ||||||||
| The accounts have been prepared under the historical cost convention. | ||||||||
| The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 . | ||||||||
| 1b. Going Concern | ||||||||
| The company has negative net assets and is reliant upon the support of the directors to continue its activities. These financial statements have been prepared on the going concern basis on the grounds that the directors have indicated that their financial support will continue for the forseeable future. | ||||||||
| 1c. Stocks | ||||||||
| Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs. | ||||||||
| When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs. | ||||||||
| 1d. Pension Costs | ||||||||
| The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year. | ||||||||
| 1e. Foreign Currency | ||||||||
| Transactions in currencies, other than the functional currency of the company, are recorded at the rate of the exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. All differences are taken to the profit and loss account. Non-monetary items that are measured at the historic cost in a foreign currency are not retranslated. | ||||||||
| MEDICAL ACCESS SPECIALISTS LIMITED | ||||||||
| 2. EMPLOYEES | ||||||
| 2025 | 2024 | |||||
| No. | No. | |||||
| Average number of employees (including directors) | 3 | |||||
| 3. STOCK | 2025 | 2024 | ||||
| £ | £ | |||||
| Stock comprises: | ||||||
| Stock | ||||||
| 4. DEBTORS | 2025 | 2024 | ||||||
| £ | £ | |||||||
| Amounts falling due within one year | ||||||||
| Trade debtors | - | 3 | ||||||
| VAT | 797 | 233 | ||||||
| 797 | 236 | |||||||
| 5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR | ||||||||
| 2025 | 2024 | |||||||
| £ | £ | |||||||
| PAYE control | 1,380 | 1,380 | ||||||
| Directors current account | 1,319 | 10,848 | ||||||
| Trade creditors | 1,182 | 2,402 | ||||||
| Accruals | 852 | 777 | ||||||
| 4,733 | 15,407 | |||||||
| 6. SHARE CAPITAL | 2025 | 2024 | ||||||
| £ | £ | |||||||
| Allotted, issued and fully paid: | ||||||||
| 200 | 200 | |||||||
| 200 | 200 | |||||||
| New shares issued during period: | ||||||||
| 200 | 200 | |||||||
| MEDICAL ACCESS SPECIALISTS LIMITED | ||||||||
| 7. CONTROLLING PARTY | ||||||||
| The company is controlled by W Denny. | ||||||||
| 8. RELATED PARTY TRANSACTIONS | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||